5-Bromo-6-methyl-3-nitro-2-pyridinamine(CAS: 68957-50-6)

5-Bromo-6-methyl-3-nitro-2-pyridinamine (CAS: 68957-50-6) is classified under the Globally Harmonized System of Classification and Labelling of Chemicals (GHS) as a category 1A carcinogen. It is also subject to the European Union's Registration, Evaluation, Authorization and Restriction of Chemicals (REACH) regulations, which require detailed safety assessments and documentation. Additionally, in the USA, it is regulated by the Environmental Protection Agency (EPA) and the Food and Drug Administration (FDA) under hazardous chemical and pharmaceutical regulations respectively.

While 5-Bromo-6-methyl-3-nitro-2-pyridinamine (CAS: 68957-50-6) is a specific compound, there are other analogs and related compounds that may be used as alternatives in synthesis, such as 2-methyl-5-nitropyridine or 6-bromo-3-nitro-2-pyridinamine. These alternatives can offer similar properties and can be used based on the specific requirements of the synthesis process.

The market for 5-Bromo-6-methyl-3-nitro-2-pyridinamine (CAS: 68957-50-6) is growing due to its applications in pharmaceuticals and research. There is a steady demand from academic and industrial research fields for its use in developing new drug candidates. Recent research trends focus on the compound's potential in antiviral and anticancer drug development.

Waste containing 5-Bromo-6-methyl-3-nitro-2-pyridinamine (CAS: 68957-50-6) should be collected in appropriate, leak-proof containers and stored in a well-ventilated area away from sources of ignition. The waste should be disposed of via incineration or a professional hazardous waste disposal service. Environmental protection measures should include proper containment to prevent spillage and ensure the waste is treated in accordance with local and national regulations.